Sigma Planning Corp Has $1.37 Million Stock Holdings in Healthpeak Properties, Inc. $DOC

Sigma Planning Corp grew its position in Healthpeak Properties, Inc. (NYSE:DOC) by 582.8% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 83,451 shares of the real estate investment trust’s stock after purchasing an additional 71,229 shares during the quarter. Sigma Planning Corp’s holdings in Healthpeak Properties were worth $1,371,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Advocate Investing Services LLC bought a new stake in shares of Healthpeak Properties during the 4th quarter worth $26,000. WPG Advisers LLC raised its holdings in Healthpeak Properties by 270.2% in the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after acquiring an additional 1,197 shares during the period. CYBER HORNET ETFs LLC bought a new position in Healthpeak Properties in the 2nd quarter worth $33,000. Clearstead Advisors LLC lifted its position in Healthpeak Properties by 166.3% during the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after acquiring an additional 1,216 shares during the last quarter. Finally, Elyxium Wealth LLC bought a new stake in Healthpeak Properties during the fourth quarter valued at about $31,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. The trade was a 59.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.23% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

DOC has been the subject of several research reports. Scotiabank increased their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 27th. Royal Bank Of Canada boosted their target price on shares of Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a research report on Thursday, May 14th. Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Mizuho upped their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, July 6th. Finally, Raymond James Financial assumed coverage on shares of Healthpeak Properties in a report on Wednesday, June 17th. They issued a “market perform” rating for the company. Four analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $20.62.

Healthpeak Properties Price Performance

NYSE:DOC opened at $22.52 on Friday. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The firm has a market cap of $15.53 billion, a PE ratio of 70.39, a price-to-earnings-growth ratio of 3.47 and a beta of 1.02. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $22.62. The company’s 50-day moving average price is $20.47 and its two-hundred day moving average price is $18.24.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The company had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the business posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 5.4%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 381.25%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.